Iterum Update on FDA Advisory Committee Discussion

 FDA Decision Expected by PDUFA Goal Date of October 25, 2024

Potential to be First Oral Penem Approved in the U.S.

https://www.globenewswire.com/news-release/2024/09/10/2943519/0/en/Iterum-Therapeutics-Provides-Update-on-FDA-Advisory-Committee-Discussion-of-Oral-Sulopenem-for-the-Treatment-of-uUTI-in-Adult-Women.html